Nikolai Muhlberger
Overview
Explore the profile of Nikolai Muhlberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crispin A, Rehms R, Hoffmann S, Lindoerfer D, Hallsson L, Jahn B, et al.
Dtsch Arztebl Int
. 2023 Oct;
120(46):786-792.
PMID: 37855423
Background: Persons with a positive family history of colorectal cancer (CRC) are more likely than others to develop CRC and are also younger at the onset of the disease. Nonetheless,...
2.
Sroczynski G, Hallsson L, Muhlberger N, Jahn B, Rehms R, Hoffmann S, et al.
Int J Cancer
. 2023 Oct;
154(3):516-529.
PMID: 37795630
Individuals with a family history of colorectal cancer (CRC) may benefit from early screening with colonoscopy or immunologic fecal occult blood testing (iFOBT). We systematically evaluated the benefit-harm trade-offs of...
3.
Schmucker C, Thorel E, Flatscher-Thoni M, Sow D, Gohner A, Stuhlinger V, et al.
Dtsch Arztebl Int
. 2023 Sep;
120(44):747-753.
PMID: 37656479
Background: In this systematic review, we address the question whether children and adolescents with developmental visual disorders benefit from computer-assisted visual training. Methods: Systematic literature searches were carried out in...
4.
Sturzlinger H, Conrads-Frank A, Eisenmann A, Invansits S, Jahn B, Janzic A, et al.
Ger Med Sci
. 2023 Jul;
21:Doc06.
PMID: 37426885
Background: Stool DNA testing for early detection of colorectal cancer (CRC) is a non-invasive technology with the potential to supplement established CRC screening tests. The aim of this health technology...
5.
Kuehne F, Arvandi M, Hess L, Faries D, Matteucci Gothe R, Gothe H, et al.
J Clin Epidemiol
. 2022 Oct;
152:269-280.
PMID: 36252741
Background And Objectives: Drawing causal conclusions from real-world data (RWD) poses methodological challenges and risk of bias. We aimed to systematically assess the type and impact of potential biases that...
6.
Bicher M, Rippinger C, Zechmeister M, Jahn B, Sroczynski G, Muhlberger N, et al.
PLoS One
. 2022 May;
17(5):e0265957.
PMID: 35499997
Background And Objective: The distribution of the newly developed vaccines presents a great challenge in the ongoing SARS-CoV-2 pandemic. Policy makers must decide which subgroups should be vaccinated first to...
7.
Schnell-Inderst P, Laschkolnig A, Marckmann G, Antony D, Siebert U, Muhlberger N
Gesundheitswesen
. 2021 Dec;
85(4):234-241.
PMID: 34872119
Background: Testicular cancer occurs mainly in young men between 25 and 45 years and is the most common cancer at this age. Possible testicular cancer early detection measures, clinical palpation...
8.
Muhlberger N, Sroczynski G, Gogollari A, Jahn B, Pashayan N, Steyerberg E, et al.
Eur J Health Econ
. 2021 Aug;
22(8):1311-1344.
PMID: 34342797
Objectives: Benefit and cost effectiveness of breast cancer screening are still matters of controversy. Risk-adapted strategies are proposed to improve its benefit-harm and cost-benefit relations. Our objective was to perform...
9.
Jahn B, Sroczynski G, Bicher M, Rippinger C, Muhlberger N, Santamaria J, et al.
Vaccines (Basel)
. 2021 Apr;
9(5).
PMID: 33925650
(1) Background: The Austrian supply of COVID-19 vaccine is limited for now. We aim to provide evidence-based guidance to the authorities in order to minimize COVID-19-related hospitalizations and deaths in...
10.
Schaffner M, Rochau U, Muhlberger N, Conrads-Frank A, Qerimi Rushaj V, Sroczynski G, et al.
Endocr Connect
. 2020 Dec;
10(1):1-12.
PMID: 33263563
Objective: More than 30% of the German population suffers from mild to moderate iodine deficiency causing goiter and other iodine deficiency disorders (IDDs). The economic burden of iodine deficiency is...